UPDATED Apr 18, 2024
Popular and high growth companies which might be overvalued.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VACN | CHF472.20 | -3.8% | 52.8% | CHF14.2b | CHF456.31 | PE74.4x | E21.2% | 1.3% | Capital Goods | ||
SRAIL | CHF27.85 | -1.1% | -22.9% | CHF2.8b | CHF30.62 | PE22.4x | E23.4% | 3.2% | Capital Goods | ||
COPN | CHF71.20 | 2.3% | 29.9% | CHF1.1b | CHF93.67 | PE1026x | E30.4% | 2.7% | Pharmaceuticals & Biotech | ||
INA | CHF18.45 | 6.0% | 2.5% | CHF305.4m | CHF17.20 | PS15.1x | E39.8% | n/a | Real Estate Management and Development |